Your chance to get in with the fund crowd

... Babraham-based Cell Guidance Systems (CGS). The cash will buy a 12.37% share in CGS, which is involved in stem cell research to create drugs to treat stroke, spinal injury, heart disease and many others. The founders say that by instantly connecting ...

http://www.cambridge-news.co.uk/Business/Business-News/Your-chance-to-get-in-with-the-fund-crowd-19022013.htm